The Economic Impact of Herpes Zoster Vaccine Disparities in Elderly United States Blacks

• Main Authors: La’Marcus T. Wingate, Keisha Stubbs, Iman Ahmed, Rachel K. Mayaka, Mary K. Maneno, Earl Ettienne, Oluchi Elekwachi, Veronica Clarke-Tasker
• Format: Article
• Language: English
• Published: MDPI AG 2018-09-01
• Series: International Journal of Environmental Research and Public Health
• Subjects: herpes zoster; shingles; vaccination; elderly; blacks; seniors
• Online Access: http://www.mdpi.com/1660-4601/15/10/2128
• ISSN: 1660-4601

There are persistent disparities with regard to receipt of herpes zoster vaccine among elderly blacks, but no data is available regarding the public health or economic impact of these disparities. A decision tree was constructed with multiple Markov nodes in order to estimate the preventable cases of herpes zoster occurring among elderly blacks due to disparities in receipt of herpes zoster vaccine and to quantify the economic costs associated with these disparities. The model was constructed to examine the number of herpes zoster cases occurring among elderly blacks from the age of 60 to 84 over a 20 year period and also calculated costs due to herpes zoster complications and lost productivity. Achievement of health equity would prevent over 34,500 cases of herpes zoster from occurring in the future and avert over $180 million in lost productivity and treatment costs as a result of these cases of herpes zoster. These results help to show that thousands of cases of herpes zoster could be prevented if blacks were vaccinated at the same frequency as whites and help to show the benefit of implementing viable strategies to achieving this goal.